Market Tracker

08/18 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.86
Delayed Data
As of 4:09pm ET
 -0.06 / -3.12%
Today’s Change
1.27
Today|||52-Week Range
7.10
+31.08%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close1.92
Today’s open1.92
Day’s range1.82 - 1.95
Volume159,292
Average volume (3 months)387,328
Market cap$54.6M
Dividend yield--
Data as of 4:09pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-240.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.15+7.50%
ECYTEndocyte Inc-0.07-5.47%
INFIInfinity Pharmaceuti...-0.09-8.26%
OVASOvaScience Inc-0.04-2.67%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts